Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imipenem-Relebactam Pharmacokinetics in Obese ICU Patients
NCT05146154Phase 4Withdrawn
- Sponsor
- University of Illinois Chicago
- Start
- Jan 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of imipenem + cilastatin + relebactam in bacterial infection, sponsored by University of Illinois Chicago. Planned start Jan 2023; status: withdrawn.
02
Drugs
imipenem + cilastatin + relebactam
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT05146154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05146154.